Stay updated with breaking news from Pediatric Study Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: ABIVAX / Key word(s): Study Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD 20.12...
This white paper examines specific considerations and planning for pediatric oncology trials, and the changing landscape in pediatric oncology...
11.08.2022 - $5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision ...
Announcement of First Dosage for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ Platform KANSAS CITY, Kan., May 12, 2022 -- Cingulate Inc. , a... | May 12, 2022
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and...